Neovascular Age-Related Macular Degeneration (AMD) Treatment Market: Growth, Competitive Landscape, and Future Outlook
The neovascular age-related macular degeneration (AMD) treatment market, valued at USD 11 billion in 2023 across seven major markets, is undergoing a transformative phase. Driven by rapid advancements in treatment technologies, this market is set to grow significantly at a compound annual growth rate (CAGR) of 7.5%, reaching an anticipated value of USD 21.1 billion…